Lacomed (Lacosamide)

Lacosamide is an anticonvulsant that acts on neuronal sodium channels to control seizure activity.

• Partial‑onset seizures: reduces the frequency and severity of focal seizures.
• Epilepsy (adjunct therapy): provides additional seizure control when other agents are insufficient.
• Refractory focal epilepsy: offers an alternative option for patients not responding to standard treatments.

• Lacosamide enhances the slow inactivation of voltage‑gated sodium channels in neuronal membranes, stabilizing hyper‑excitable neuronal membranes and diminishing repetitive firing. This modulation reduces neuronal hyperexcitability that underlies seizure generation, thereby contributing to seizure control in epilepsy.

Lacosamide may cause a range of adverse reactions, from mild to serious.

Common Side Effects

• Dizziness: transient sensation of light‑headedness.
• Nausea: mild gastrointestinal upset.
• Headache: occasional tension‑type headache.
• Fatigue: feeling of tiredness or reduced energy.
• Diplopia: temporary double vision.
• Tremor: mild shaking of hands or limbs.

Serious or Rare Side Effects

• Cardiac arrhythmia: irregular heart rhythm, especially PR‑interval prolongation.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Suicidal ideation: emergence of thoughts of self‑harm.
• Acute pancreatitis: inflammation of the pancreas.
• Hepatic dysfunction: elevated liver enzymes or liver injury.

Patients should be aware of specific safety considerations when using Lacomed.

• Cardiac monitoring: obtain baseline ECG and monitor PR interval during therapy.
• Renal impairment: adjust dosing in patients with reduced kidney function.
• Hepatic impairment: use caution and consider dose adjustment in liver disease.
• Concomitant CNS depressants: monitor for enhanced sedation or respiratory depression.
• Pregnancy and lactation: discuss potential risks with a healthcare professional before use.
• Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and light.

Lacosamide can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

• CYP2C19 inhibitors (e.g., fluconazole, omeprazole): may increase lacosamide plasma levels.
• Cardiac conduction agents (e.g., digoxin, quinidine): can exacerbate PR‑interval prolongation.

Moderate Interactions (Monitor Closely)

• Other antiepileptics (e.g., carbamazepine, phenytoin): may alter seizure control.
• CNS depressants (e.g., benzodiazepines, opioids): increase risk of sedation.
• Alcohol: may potentiate dizziness and drowsiness.
• Diuretics (e.g., furosemide): monitor electrolytes and renal function.